Notably, eleven out of nineteen patients with KMT2A-rearranged AML (58%) and five out of eight patients with complex karyotype AML (63%) had high BM T cell infiltration (Fig. 1F). This evidence concerns the gene KMT2A and acute myeloid leukemia.